Markets.com Logo

APTO

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    1.1025$
  • Previous Close
    2.0085$
  • 52 Week Change
    37.00$
  • Day Range
    -0.91$
  • 52 Week High/Low
    1.1$ - 38.1$
  • Dividend Per Share
    --
  • Market cap
    4 365 K$
  • EPS
    -34.9
  • Beta
    1.134
  • Volume
    --

About

APTO.US is the stock ticker symbol for Aptose Biosciences Inc., a clinical-stage biotechnology company. Aptose Biosciences focuses on discovering and developing targeted therapeutics in oncology, particularly related to hematologic malignancies. The company's pipeline includes compounds designed to target key cellular signaling pathways involved in cancer cell growth and survival. Aptose Biosciences is listed on the Nasdaq Stock Market under the symbol APTO.

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Meta Platforms: Navigating Legal Headwinds and AI Opportunities for Investors

Liam James|--

US Stocks Poised for Potential Rebound Amidst Easing Geopolitical Tensions and Shifting Investor Positioning

Sophia Claire|--
UAE as Global Gold Powerhouse: Analyzing the 2026 Resilience of Dubai’s Gold Trading Ecosystem

UAE as Global Gold Powerhouse: Analyzing the 2026 Resilience of Dubai’s Gold Trading Ecosystem

Ghko B|--
Trade Desk (TTD) Analysis: Is the 2026 Tech Dip a Strategic Entry Point for UAE Investors?

Trade Desk (TTD) Analysis: Is the 2026 Tech Dip a Strategic Entry Point for UAE Investors?

Ghko B|--
Cryptocurrency-related stocks analysis: MicroStrategy (MSTR) stock, BMNR stock, Coinbase

Cryptocurrency-related stocks analysis: MicroStrategy (MSTR) stock, BMNR stock, Coinbase

Ghko B|--

Factors

Clinical Trial Results: Positive results from clinical trials often lead to increased investor confidence and a higher stock price, while negative results can cause a significant drop.

Regulatory Approval: Approval from regulatory bodies like the FDA for Apto's drugs is a major catalyst for price increases. Conversely, rejection or delays can negatively impact the stock.

Competition: The presence of competing drugs or therapies in the market can affect Apto's market share and profitability, influencing the stock price.

Financial Performance: Revenue, earnings, and profitability reports significantly affect investor sentiment. Strong financial performance generally boosts the stock price.

Market Conditions: Overall market trends, sector performance (biotechnology), and economic conditions play a role. Bull markets tend to lift most stocks, while bear markets can pressure prices downward.

Partnerships & Collaborations: Strategic partnerships with other pharmaceutical companies or research institutions can signal future growth and positively affect the stock price.

Management Decisions: Key decisions made by Apto's management team, such as acquisitions, divestitures, or changes in strategy, can impact investor perception and the stock's value.

Analyst Ratings: Ratings and price targets issued by financial analysts can influence investor behavior and stock price movements.

Investor Sentiment: General investor optimism or pessimism towards biotechnology stocks, or Apto in particular, can drive price fluctuations.

Patent Protection: The strength and duration of Apto's patent portfolio is crucial for protecting its intellectual property and future revenue streams, affecting the stock price.

Debt Levels: High debt levels can increase financial risk and negatively impact investor confidence, potentially lowering the stock price.

Cash Flow: Apto's ability to generate positive cash flow is an indicator of its financial health and sustainability, influencing investor perception and stock value.

Pipeline Progress: Advancement of Apto's drug candidates through the development pipeline (Phase 1, 2, 3 trials) can signal future revenue potential and positively affect the stock.

Economic Factors: Inflation, interest rates, and overall economic growth or recession can influence investor risk appetite and affect stock valuations across the board.

Company News: Press releases regarding new developments, partnerships, or updates on clinical trials can lead to significant price changes based on the information presented.

People Also Watch

Latest news

Ukraine Forges New Alliances in the Middle East, Leveraging Defense Expertise

Sophia Claire|--

US Reinforces Middle East Presence Amid Escalating Tensions with Iran

Noah Lee|--

Fed Policy Pivot: Inflation Risks Hint at Potential Rate Hikes, Shifting Market Expectations

Sophia Claire|--

Latest Education Articles

S&P 500, Nasdaq, Dow & Russell 2000: Important Technical Levels Traders Should Watch

S&P 500, Nasdaq, Dow & Russell 2000: Important Technical Levels Traders Should Watch

Ghko B|--
What is CCI strategy: What is the formula for Commodity Channel Index?

What is CCI strategy: What is the formula for Commodity Channel Index?

Ghko B|--
Relative Strength Index (RSI) in trading: RSI indicator buy and sell signals, RSI explained with examples

Relative Strength Index (RSI) in trading: RSI indicator buy and sell signals, RSI explained with examples

Ghko B|--